Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2023 | 08-2023 | 05-2023 | 02-2023 | 11-2022 | |
| Sales | 151 | 31 | 78 | 20 | 98 |
| Cost of Goods | 5 | N/A | 13 | 3 | 16 |
| Gross Profit | 147 | 31 | 65 | 17 | 82 |
| Operating Expenses | 1,290 | 1,145 | 2,479 | 1,344 | 1,793 |
| Operating Income | -1,139 | -1,114 | -2,401 | -1,324 | -1,695 |
| Other Income | -46 | -135 | 17 | 13 | -74 |
| Pre-tax Income | -1,185 | -1,249 | -2,384 | -1,311 | -1,769 |
| Net Income Continuous | -1,185 | -1,249 | -2,384 | -1,311 | -1,769 |
| Minority Interests | -6 | -10 | -12 | -13 | -13 |
| Net Income | $-1,179 | $-1,239 | $-2,372 | $-1,298 | $-1,756 |
| EPS Basic Total Ops | -0.13 | -0.12 | -0.37 | -0.22 | -0.30 |
| EPS Basic Continuous Ops | -0.13 | -0.13 | -0.37 | -0.22 | -0.30 |
| EPS Diluted Total Ops | -0.13 | -0.12 | -0.37 | -0.22 | -0.30 |
| EPS Diluted Continuous Ops | -0.13 | -0.13 | -0.37 | -0.22 | -0.30 |
| EBITDA(a) | $-1,110 | $-1,043 | $-2,376 | $-1,299 | $-1,671 |